Instrument Inactif

Communiqués Gemina Laboratories Ltd.

Actions

GLAB

CA3686501071

Equipement, fournitures et distribution médicale

Communiqués

13/07	Gemina Announces Private Placement Offering	AQ
25/03	Gemina Laboratories Ltd. Announces Delisting from the CSE	AQ
23/02	Gemina Laboratories : Proxy Form (ab3f9757b)	PU
23/02	Gemina Laboratories : Notice of Meeting (dd3d7a442)	PU
19/02	Gemina Laboratories : Financial Statement Request Form (79af62610)	PU
30/12	Canadian Investment Regulatory Organization Trade Resumption - GLAB	AQ
30/12	Canadian Investment Regulatory Organization Trading Halt - GLAB	AQ
20/06/24	Gemina Laboratories : Commences Trading on	PU
17/06/24	Gemina Labs to Present at the Life Science Investor Forum June 20th	AQ
11/04/24	Gemina Laboratories : Financial Statement Request Form	PU
11/04/24	Gemina Laboratories : Notice of Meeting and Management Information Circular	PU
10/10/23	READYGO DIAGNOSTICS INITIATES AN ASSAY DEVELOPMENT CONTRACT WITH GEMINA LABORATORIES FOR THE DETECTION OF DENGUE FROM SALIVA SAMPLES	AQ
15/06/23	Gemina Laboratories : to participate in poster session at AACC scientific meeting	PU
05/06/23	READYGO DIAGNOSTICS AND GEMINA LABORATORIES ANNOUNCE THE FEASIBILITY OF MYCOBACTERIUM TUBERCULOSIS (MTB) DIAGNOSIS IN SALIVA	AQ
19/04/23	READYGO DIAGNOSTICS AND GEMINA LABORATORIES ENTER AN ASSAY DEVELOPMENT AGREEMENT FOR THE RAPID DETECTION OF MYCOBACTERIUM TUBERCULOSIS (MTB)	AQ
21/12/22	Gemina Labs Appoints Dr Michael Shannon as Chair of Clinical Advisory Board	AQ
14/09/21	Gemina Laboratories : LABS PROVIDES RESEARCH AND DEVELOPMENT AND CORPORATE UPDATE	AQ
09/08/21	CSE Bulletin: New Listing - Gemina Laboratories Ltd. (GLAB)	NE
30/11/-1	Debenture Offering and Delisting	AQ
30/11/-1	Gemina Laboratories Announces Termination of Transaction	AQ